on 19 Jan 2021
Last Applicant/ Owned by
C/- BARD1 Life Sciences Ltd,
AU
Serial Number
79274546 filed on 08th Nov 2019
Registration Number
6248001 registered on 19th Jan 2021
Correspondent Address
Charles G. Zug
Nelson Mullins Riley & Scarborough LLP
Suite 2300, IP Department
301 S. College St.
Charlotte NC 28202
Filing Basis
No Filing Basis
Disclaimer
NO DATA
Pharmaceutical preparations and substances for the treatment and/or diagnosis of cancer and infectious diseases; biotechnologically-formed enzyme preparations for medical purposes; medicinal preparations for the treatment of cancer and infectious diseases; monoclonal antibodies for therapeutic purposes; products containing antibodies for use in medicine, namely, diagnostic kits consisting primarilRead More
Pharmaceutical preparations and substances for the treatment and/or diagnosis of cancer and infectious diseases; biotechnologically-formed enzyme preparations for medical purposes; medicinal preparations for the treatment of cancer and infectious diseases; monoclonal antibodies for therapeutic purposes; products containing antibodies for use in medicine, namely, diagnostic kits consisting primarily of monoclonal antibodies used in the capture of specific biological markers for use in disease testing; proteins for binding antibodies for medical use; proteins for detecting antibodies for medical use; reagents for medical use, namely, for use in the development of monoclonal antibodies; diagnostic biomarker reagents for medical purposes; tagged antibodies for medical use; vaccines; vaccines against cancer, viral, and bacterial infection; vaccines for human use; diagnostic preparations and reagents for medical purposes; vaccine adjuvants; diagnostic preparations, reagents, and substances for medical purposes; diagnostic products and testing materials for medical purposes, namely, diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in capturing and purifying specific biological markers for use in disease testing; reagents for use in diagnostic tests for medical purposes; medical diagnostic reagents for capturing and purifying specific biological markers that can be utilised in therapeutics or diagnostics; cells for growing recombinant human protein for medical purposes; recombinant DNA technology proteins for medical use; biological reagents for use in molecular biology, namely, reagents for medical use for capturing and purifying specific biological markers that contain nucleic acid; antibodies that are specifically able to bind and capture specific biological markers for medical purposes; antibody fragments that are specifically able to bind and capture specific biological markers for medical purposes; antibody conjugates that are specifically able to bind and capture specific biological markers for medical purposes; pharmaceutical preparations for the treatment, reconstruction and repair of antibodies; immunological antibodies for medical use; monoclonal antibodies for medical diagnostic use; monoclonal antibodies for medical use
No 79274546
No Service/Collective Mark
No 065491/09000
No
No
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
16th May 2021 | FINAL DECISION TRANSACTION PROCESSED BY IB |
23rd Apr 2021 | FINAL DISPOSITION NOTICE SENT TO IB |
23rd Apr 2021 | FINAL DISPOSITION PROCESSED |
19th Apr 2021 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
29th Jan 2021 | CHANGE OF NAME/ADDRESS REC'D FROM IB |
19th Jan 2021 | REGISTERED-PRINCIPAL REGISTER |
03rd Nov 2020 | PUBLISHED FOR OPPOSITION |
03rd Nov 2020 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
02th Nov 2020 | NOTIFICATION PROCESSED BY IB |
14th Oct 2020 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |